This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
ASCO 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: Update on Southwest Oncology Group Study 9109 - Abstract
May 3, 2012
Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection - Abstract
May 3, 2012
Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden - Abstract
May 3, 2012
Docetaxel-based systemic chemotherapy in elderly Korean men with castration-resistant prostate cancer - Abstract
May 3, 2012
Phase II trial of weekly ixabepilone in men with metastatic castrate-resistant prostate cancer (E3803): A Trial of the Eastern Cooperative Oncology Group - Abstract
May 3, 2012
Dose reduction in LDR brachytherapy by implanted prostate gold fiducial markers - Abstract
May 3, 2012
Multiple rechallenges for castration-resistant prostate cancer patients responding to first-line docetaxel: Assessment of clinical outcomes and predictive factors - Abstract
May 3, 2012
Environmental exposures and prostate cancer - Abstract
May 3, 2012
TGFβ1 SNPs and radio-induced toxicity in prostate cancer patients - Abstract
May 3, 2012
Very late prostate cancer local recurrence 23 years after radical prostatectomy - Abstract
May 2, 2012
Technical note: Suppression of artifacts arising from simultaneous cone-beam imaging and RF transponder tracking in prostate radiotherapy - Abstract
May 2, 2012
Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer - Abstract
May 2, 2012
Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: A large cohort study - Abstract
May 2, 2012
Concordance of tumor differentiation among brothers with prostate cancer - Abstract
May 2, 2012
Germline predictors of androgen deprivation therapy response in advanced prostate cancer - Abstract
May 2, 2012
Factors affecting health-related quality of life in prostate cancer patients - Abstract
May 2, 2012
Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer - Abstract
May 1, 2012
Is prostate biopsy essential to diagnose prostate cancer in the older patient with extremely high prostate-specific antigen? - Abstract
May 1, 2012
Software-controlled, highly automated intrafraction prostate motion correction with intrafraction stereographic targeting: System description and clinical results - Abstract
May 1, 2012
Incidence of prostate cancer in Lithuania after introduction of the Early Prostate Cancer Detection Programme - Abstract
May 1, 2012
Page 1291 of 1428
Start
Prev
1286
1287
1288
1289
1290
1291
1292
1293
1294
1295
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free